Total Payments
$70,161
2024 Payments
$3,042
Companies
10
Transactions
84
Payment Breakdown by Category
Consulting$36,159 (51.5%)
Travel$28,675 (40.9%)
Other$2,985 (4.3%)
Food & Beverage$2,342 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $36,159 | 16 | 51.5% |
| Travel and Lodging | $28,675 | 25 | 40.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,985 | 2 | 4.3% |
| Food and Beverage | $2,342 | 41 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $28,849 | 47 | $0 (2019) |
| AstraZeneca UK Limited | $16,711 | 10 | $0 (2017) |
| AstraZeneca AB | $11,969 | 5 | $0 (2018) |
| GlaxoSmithKline, LLC. | $4,208 | 10 | $0 (2019) |
| Grifols USA, LLC | $3,535 | 6 | $0 (2017) |
| Inova Diagnostics, Inc. | $3,024 | 1 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,594 | 2 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $137.97 | 1 | $0 (2022) |
| Circassia Pharmaceuticals Inc | $115.18 | 1 | $0 (2018) |
| ViiV Healthcare Company | $17.67 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,042 | 2 | Inova Diagnostics, Inc. ($3,024) |
| 2022 | $137.97 | 1 | Regeneron Healthcare Solutions, Inc. ($137.97) |
| 2019 | $1,146 | 3 | AstraZeneca Pharmaceuticals LP ($900.00) |
| 2018 | $39,170 | 45 | AstraZeneca Pharmaceuticals LP ($21,875) |
| 2017 | $26,665 | 33 | AstraZeneca UK Limited ($16,711) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: HIV | ||||||
| 06/21/2024 | Inova Diagnostics, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,024.00 | General |
| 05/16/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $137.97 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Respiratory | ||||||
| 11/07/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.11 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $122.04 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2018 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2018 | AstraZeneca Pharmaceuticals LP | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $465.00 | General |
| 07/08/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| Category: Respiratory | ||||||
| 06/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Consulting Fee | Cash or cash equivalent | $1,545.00 | General |
| Category: RESPIRATORY | ||||||
| 06/04/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $5,850.00 | General |
| Category: Respiratory | ||||||
| 06/04/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $1,380.00 | General |
| 06/04/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $212.95 | General |
| 06/04/2018 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $196.54 | General |
| 05/20/2018 | Circassia Pharmaceuticals Inc | NIOX VERO (Device) | Food and Beverage | In-kind items and services | $115.18 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 05/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $49.44 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.90 | General |
| 05/10/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| Category: Respiratory | ||||||
| 04/29/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Respiratory | ||||||
| 04/29/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| Category: Respiratory | ||||||
| 04/29/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $870.00 | General |
| Category: Respiratory | ||||||
| 04/29/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Consulting Fee | Cash or cash equivalent | $435.00 | General |
| Category: Respiratory | ||||||
| 04/22/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $2.80 | General |
| 04/21/2018 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.75 | General |
| 04/18/2018 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Travel and Lodging | In-kind items and services | $1,621.41 | General |
| Category: Respiratory | ||||||
About Dr. Xavier Soler, M.D
Dr. Xavier Soler, M.D is a Pulmonary Disease healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2009. The National Provider Identifier (NPI) number assigned to this provider is 1962738641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Xavier Soler, M.D has received a total of $70,161 in payments from pharmaceutical and medical device companies, with $3,042 received in 2024. These payments were reported across 84 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($36,159).
Ad
Practice Information
- Specialty Pulmonary Disease
- Location San Diego, CA
- Active Since 10/30/2009
- Last Updated 08/10/2017
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1962738641
Products in Payments
- BEVESPI AEROSPHERE (Drug) $13,394
- FASENRA (Drug) $13,208
- Prolastin-C (Biological) $3,535
- SYMBICORT (Drug) $1,860
- STIOLTO RESPIMAT (Drug) $1,545
- ANORO ELLIPTA (Drug) $345.00
- NUCALA (Biological) $247.01
- DUPIXENT (Biological) $137.97
- TRELEGY ELLIPTA (Drug) $124.11
- NIOX VERO (Device) $115.18
- SPIRIVA (Drug) $49.44
- CABENUVA (Biological) $17.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in San Diego
Dr. George Cheng, Md Phd, MD PHD
Pulmonary Disease — Payments: $230,134
Pulmonary Disease $230,134
Dr. Xuanha White, D.o, D.O
Pulmonary Disease — Payments: $216,172
Pulmonary Disease $216,172
Praveen Akuthota, M.d, M.D
Pulmonary Disease — Payments: $183,353
Pulmonary Disease $183,353
Wael El Maraachli, Md, MD
Pulmonary Disease — Payments: $114,418
Pulmonary Disease $114,418
Dr. Demosthenes Papamatheakis, Md, MD
Pulmonary Disease — Payments: $111,552
Pulmonary Disease $111,552
Dr. Robert Owens, Md, MD
Pulmonary Disease — Payments: $106,126
Pulmonary Disease $106,126